asthmatic fibrocytes (1-EBIO-dependent current at +40 mV 9696216 pA; n¼17 cells) compared to healthy fibrocytes (1-EBIO-induced current 506694 pA; n¼30 cells; p¼0.029). K Ca 3.1 currents were blocked by the selective K Ca 3.1 blocker TRAM-34. The migration of differentiated fibrocytes induced by airway smooth muscle supernatant was inhibited by 71.166.9 % by TRAM-34 200 nM (p<0.0001). The CXCL12-dependent migration of fibrocyte progenitors within a freshly isolated PBMC population was reduced by 70.967.9% by TRAM-34 (p¼0.003). Conclusions The K + channel K Ca 3.1 is expressed in human fibrocytes, and plays a key role in their migration. K Ca 3.1 blockers may therefore offer a novel approach to the treatment of airway wall remodelling in asthma, and parenchymal fibrosis in idiopathic pulmonary fibrosis. 
S46

